Latest filing published 13 May 2019 for Trevi Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -68.4%Entry US$8.90 · Close at T+365 US$2.81
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Richard King Mellon Foundation: trading record in brief
Richard King Mellon Foundation is a declared insider of Trevi Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 3 filings, all for trades on 9 May 2019.
No open-market sale appears; the market trades are 1 purchase worth €891k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 13 May 2019 came the latest disclosure, a transaction in Trevi Therapeutics, Inc. The clock since the last published purchase (13 May 2019) now reads 2,737 days. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richard King Mellon Foundation
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 222,816 sharesCommon StockSEC:0000899243-19-013252:0
- 24,341 shares0Common StockSEC:0000899243-19-013252:1
- 100,000 shares@ US$10.00100.0% of flowCommon StockSEC:0000899243-19-013252:2Canonical exit: 7 Aug 2019 (T+90)
3 of 3 declarations
